IRANIAN JOURNAL OF PEDIATRICS, vol.23, no.6, pp.693-700, 2013 (SCI-Expanded)
Objective: To determine the risk factors associated with lower respiratory tract infections (LRTI) related hospitalizations in preterm infants receiving palivizumab throughout the high season for respiratory syncytial virus (RSV) infection.